| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac310b7e9eed8849a70413d61dc3f40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55887adc7772bc1dd06bc9dd54835494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43610833b77819f47566d192b7c78f48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14fe4baa5402fb01f1012eb9c9438b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a0c58ed8355584f9064b24aa63494f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b4e2f6c86ba110f1f963763b17c69d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dae100a8a936220540d1734370e84c8a |
| publicationDate |
2022-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022079221-A1 |
| titleOfInvention |
Rna compositions and methods for inhibiting lipoprotein(a) |
| abstract |
The present disclosure relates to dsRNAs targeting LPA mRNA and modulating Lp(a) plasma levels, and methods of treating one or more conditions associated with LPA gene expression. |
| priorityDate |
2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |